OTC Markets OTCPK - Delayed Quote USD

Pharmagreen Biotech Inc. (PHBI)

0.0013

+0.0002

+(18.18%)

At close: May 2 at 4:00:00 PM EDT

Pharmagreen Biotech Inc. (PHBI) Announces Exciting Revenue Potential for Its Project

CARSON CITY, Nev., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc. (OTC PINKS: PHBI) ("Pharmagreen" or the "Company") is thrilled to highlight the significant revenue potential from its latest project under development. During a special session on Creative Spaces, hosted on X on Monday, October 7, 2024, CEO Peter Wojcik shared exciting insights into the company's business advancements and growth strategies. Pharmagreen is developing a specialized form of cannabis oil known as Live Ro

GlobeNewswire 6 months ago

PHBI
+18.18%
Pharmagreen Biotech, Inc. (PHBI) Reaffirms Commitment to Non-Toxic Financing Amid Ongoing Business Development Progress

CARSON CITY, NV, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc. (OTC PINKS: PHBI) ("Pharmagreen" or the "Company") is pleased to announce the continued advancement of its business development efforts on a significant project in collaboration with a foreign government. Considerable progress has been made, and the Company is optimistic about the wide-ranging benefits this initiative will bring to all involved parties. By incorporating Pharmagreen’s proprietary Standard Organic Non-Sp

GlobeNewswire 7 months ago

PHBI
+18.18%

Performance Overview

Return	PHBI	S&P 500 (^GSPC)
YTD	-13.33%	-3.31%
1-Year	+85.71%	+12.29%
3-Year	-89.26%	+36.85%